Bilcare Limited carries a market capitalization of 1.46B, placing it among publicly traded companies globally. Its enterprise value stands at 5.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.46B |
| Enterprise Value | 5.69B |
Bilcare Limited currently has 23.55M shares outstanding.
| Shares Outstanding | 23.55M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.17, and the price-to-book ratio stands at 5.27.
| PE Ratio | N/A |
| PS Ratio | 0.17 |
| PB Ratio | 5.27 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Bilcare Limited trades at an EV/EBITDA multiple of 144.89 and an EV/FCF ratio of 8.73. The EV/Sales ratio of 0.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 144.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.78 |
| EV / EBITDA | 144.89 |
| EV / EBIT | 144.89 |
| EV / FCF | 8.73 |
Bilcare Limited maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 836.85, indicating elevated leverage, while an interest coverage ratio of 0.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.21 |
| Quick Ratio | 0.18 |
| Debt / Equity | 836.85 |
| Debt / EBITDA | 157.87 |
| Interest Coverage | 0.05 |
| Return on Equity (ROE) | -24.12 |
| Return on Assets (ROA) | -0.77 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.22 |
| Income Tax | -41.70M |
| Effective Tax Rate | N/A |
Bilcare Limited's stock has declined approximately -13.68056% over the past 52 weeks. The 50-day moving average sits at 61.87, while the 200-day moving average is 71.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.68056% |
| 50-Day Moving Average | 61.87 |
| 200-Day Moving Average | 71.79 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bilcare Limited generated 7.34B in revenue and converted that into -86.70M in net income, yielding earnings per share of -16.18. EBITDA reached 39.30M, while operating income came in at 39.30M.
| Revenue | 7.34B |
| Gross Profit | 2.44B |
| Operating Income | 39.30M |
| Pretax Income | -422.10M |
| Net Income | -86.70M |
| EBITDA | 39.30M |
| EBIT | 39.30M |
| Earnings Per Share (EPS) | -16.18 |
Bilcare Limited holds 524.90M in cash and equivalents against 6.20B in total debt, resulting in a net debt position of 6.04B. Total book value stands at 235.50M, with working capital of 611.60M providing operational flexibility.
| Cash & Cash Equivalents | 524.90M |
| Total Debt | 6.20B |
| Net Debt | 6.04B |
| Equity (Book Value) | 235.50M |
| Book Value Per Share | 10.02 |
| Working Capital | 611.60M |
Bilcare Limited operates with a gross margin of 33.21, reflecting its pricing power and cost economics. The operating margin of 0.54 and net profit margin of -1.18 provide insight into operational efficiency.
| Gross Margin | 33.21 |
| Operating Margin | 0.54 |
| Pretax Margin | -5.75 |
| Profit Margin | -1.18 |
| EBITDA Margin | 0.54 |
Bilcare Limited's most recent stock split took place on December 12, 2003 with a 1:3 split ratio.
| Last Split Date | 12/12/2003 |
| Split Ratio | 1:3 |
Bilcare Limited posts an Altman Z-Score of 1.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.08 |